STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942,842 | -68.5% | 239,300 | -15.1% | 0.00% | -69.2% |
| Q2 2023 | $2,995,534 | -8.5% | 281,800 | -28.3% | 0.01% | -27.8% |
| Q1 2023 | $3,273,690 | -17.2% | 393,000 | -8.2% | 0.02% | -5.3% |
| Q4 2022 | $3,952,286 | -65.7% | 428,200 | -52.3% | 0.02% | -66.1% |
| Q3 2022 | $11,516,000 | -4.3% | 896,900 | -1.6% | 0.06% | +5.7% |
| Q2 2022 | $12,036,000 | -57.2% | 911,100 | -31.8% | 0.05% | -45.4% |
| Q1 2022 | $28,133,000 | +21540.8% | 1,336,500 | +26105.9% | 0.10% | – |
| Q3 2021 | $130,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |